Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Injection Type
Oral Type
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
GE
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma

Table of Content
1 Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
1.1 Product Overview and Scope of Magnetic Resonance Imaging (MRI) Contrast Agents
1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Segment by Type
1.2.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection Type
1.2.3 Oral Type
1.3 Magnetic Resonance Imaging (MRI) Contrast Agents Segment by Application
1.3.1 Magnetic Resonance Imaging (MRI) Contrast Agents Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Estimates and Forecasts
1.4.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Revenue 2016-2027
1.4.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales 2016-2027
1.4.3 Magnetic Resonance Imaging (MRI) Contrast Agents Market Size by Region: 2016 Versus 2021 Versus 2027
2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Competition by Manufacturers
2.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales Market Share by Manufacturers (2016-2021)
2.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Magnetic Resonance Imaging (MRI) Contrast Agents Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Magnetic Resonance Imaging (MRI) Contrast Agents Manufacturing Sites, Area Served, Product Type
2.5 Magnetic Resonance Imaging (MRI) Contrast Agents Market Competitive Situation and Trends
2.5.1 Magnetic Resonance Imaging (MRI) Contrast Agents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Magnetic Resonance Imaging (MRI) Contrast Agents Players Market Share by Revenue
2.5.3 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Magnetic Resonance Imaging (MRI) Contrast Agents Retrospective Market Scenario by Region
3.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Facts & Figures by Country
3.3.1 North America Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Country
3.3.2 North America Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Facts & Figures by Country
3.4.1 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Country
3.4.2 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Facts & Figures by Region
3.5.1 Asia Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Region
3.5.2 Asia Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Facts & Figures by Country
3.6.1 Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Country
3.6.2 Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Facts & Figures by Country
3.7.1 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Country
3.7.2 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Magnetic Resonance Imaging (MRI) Contrast Agents Historic Market Analysis by Type
4.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales Market Share by Type (2016-2021)
4.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Revenue Market Share by Type (2016-2021)
4.3 Global Magnetic Resonance Imaging (MRI) Contrast Agents Price by Type (2016-2021)
5 Global Magnetic Resonance Imaging (MRI) Contrast Agents Historic Market Analysis by Application
5.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales Market Share by Application (2016-2021)
5.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Revenue Market Share by Application (2016-2021)
5.3 Global Magnetic Resonance Imaging (MRI) Contrast Agents Price by Application (2016-2021)
6 Key Companies Profiled
6.1 GE
6.1.1 GE Corporation Information
6.1.2 GE Description and Business Overview
6.1.3 GE Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GE Product Portfolio
6.1.5 GE Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bracco Imaging Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Guerbet Group Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hengrui Medicine Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lantheus Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 YRPG
6.6.1 YRPG Corporation Information
6.6.2 YRPG Description and Business Overview
6.6.3 YRPG Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 YRPG Product Portfolio
6.7.5 YRPG Recent Developments/Updates
6.8 BeiLu Pharma
6.8.1 BeiLu Pharma Corporation Information
6.8.2 BeiLu Pharma Description and Business Overview
6.8.3 BeiLu Pharma Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BeiLu Pharma Product Portfolio
6.8.5 BeiLu Pharma Recent Developments/Updates
7 Magnetic Resonance Imaging (MRI) Contrast Agents Manufacturing Cost Analysis
7.1 Magnetic Resonance Imaging (MRI) Contrast Agents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Magnetic Resonance Imaging (MRI) Contrast Agents
7.4 Magnetic Resonance Imaging (MRI) Contrast Agents Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Magnetic Resonance Imaging (MRI) Contrast Agents Distributors List
8.3 Magnetic Resonance Imaging (MRI) Contrast Agents Customers
9 Magnetic Resonance Imaging (MRI) Contrast Agents Market Dynamics
9.1 Magnetic Resonance Imaging (MRI) Contrast Agents Industry Trends
9.2 Magnetic Resonance Imaging (MRI) Contrast Agents Growth Drivers
9.3 Magnetic Resonance Imaging (MRI) Contrast Agents Market Challenges
9.4 Magnetic Resonance Imaging (MRI) Contrast Agents Market Restraints
10 Global Market Forecast
10.1 Magnetic Resonance Imaging (MRI) Contrast Agents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Magnetic Resonance Imaging (MRI) Contrast Agents by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Magnetic Resonance Imaging (MRI) Contrast Agents by Type (2022-2027)
10.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Magnetic Resonance Imaging (MRI) Contrast Agents by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Magnetic Resonance Imaging (MRI) Contrast Agents by Application (2022-2027)
10.3 Magnetic Resonance Imaging (MRI) Contrast Agents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Magnetic Resonance Imaging (MRI) Contrast Agents by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Magnetic Resonance Imaging (MRI) Contrast Agents by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer